By Kirstin R Matthews, Bhavana Kunisetty and Keri Sprung
The connection between Texas H.B. 810, which allows clinics to provide investigational stem cell treatments to certain patients, and a deregulation movement to increase patient access to unproven stem cell treatments is described in this report. Stem Cells and Development: http://bit.ly/2CrEDEj.
Sept. 6, 2018, 3:27 p.m.
Christopher F. Kulesza, Ph.D., is a scholar for the Child Health Policy Program, where he carries out research in child and community health policy. His current research project focuses on the influences of built and social neighborhood environments on health …
Daniel Moralí is a research associate in bioscience policy for the Center for Health and Biosciences. He is also the program manager for the Civic Scientist School Outreach Initiative. Before joining the Baker Institute, Moralí worked at the Larimer County …
November 11, 2021
This event has been postponed until spring 2022. We apologize for any inconvenience. As …
